Chase Coleman’s GoodRx Holdings GDRX Stock Holding History

Chase Coleman’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,345,000	Closed	-$76.6M	–	118
2021 Q4	$76.6M	Hold	2,345,000	–	–	0.17%	70
2021 Q3	$96.2M	Hold	2,345,000	–	–	0.18%	61
2021 Q2	$84.4M	Buy	2,345,000 +200,000	+9%	+$7.38M	0.16%	61
2021 Q1	$83.7M	Hold	2,145,000	–	–	0.19%	54
2020 Q4	$86.5M	Buy	2,145,000 +745,000	+53%	+$34.2M	0.22%	50
2020 Q3	$77.8M	Buy	+1,400,000	New	+$74.1M	0.22%	45

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $903M AUM 113.12% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $795M AUM 5.23% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $2.83B AUM 12.55% 1-Year Est. Return

RRCP

Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $3.14B AUM 46.44% 1-Year Est. Return

Chase Coleman's GDRX Position: Q1 2022 in Review

Chase Coleman sold out of GoodRx Holdings (GDRX) in Q1 2022, closing a stake of 2,345,000 shares — an estimated $76.6M sold.

Chase Coleman first reported a position in GDRX in Q3 2020 and held it in 6 quarters. The position peaked at $96.2M in Q3 2021. 167 funds tracked by Wall St. Rank hold GDRX as of Q1 2022.

Chase Coleman reported no remaining GoodRx Holdings position as of Q1 2022 after selling out during the quarter.
Chase Coleman sold 2,345,000 GoodRx Holdings shares in Q1 2022, an estimated $76.6M.
Chase Coleman first reported a position in GoodRx Holdings in Q3 2020 and held it in 6 quarters.
Chase Coleman's GoodRx Holdings position peaked at $96.2M in Q3 2021.
167 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2022.

Based on Tiger Global Management's 13F filing for Q1 2022, filed 16 May 2022.